首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1392387

全球去腎神經市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

Global Renal Denervation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年11月01日 | 出版商:

Value Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球去腎神經市場需求預計將從 2022 年的 187.28 萬美元達到 2030 年近 6,023.78 萬美元的市場規模，2023-2030 年研究期間CAGR為 54.32%。

在腎去神經術（RDN）中，高頻切除用於燒傷腎動脈的神經纖維。此過程可減少神經活動並降低血壓。目前，去腎神經術是治療高血壓的一種安全且侵入性較小的方法，可導致永久停止服用降血壓藥物。腎去神經術是一種不可逆的過程。

市場動態：

根據研究結果，推動腎臟器械市場的關鍵因素是高血壓發生率的增加和手術的長期有效性。此手術提供的優勢，例如長期效果、更短的治療時間和更高的安全性，預計將推動市場成長。替代和改進技術的可用性，例如微輸液、去腎神經系統和新興經濟體增強的醫療基礎設施是其他預計在研究期間推動市場成長的因素。儘管如此，腎去神經術過程仍面臨一些挑戰，包括該過程需要採購新設備，而新設備需要 FDA 批准，導致製程成本高且耗時。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球去腎神經市場的每個細分市場進行了包容性評估。腎去神經術產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲地區去腎神經支配市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。腎臟去神經術市場的主要參與者包括美敦力（Medtronic）、波士頓科學公司（Boston Scientific Corporation）、Kona Medical、雅培（Abbott）、CardioSonic、Renal Dynamics Limited、Ablative Solutions、Symple Surgical、ReCor Medical。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：去腎神經術公司的競爭格局

去腎神經市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Medtronic

公司簡介
公司收入
產品
最近的發展

Boston Scientific Corporation

公司簡介
公司收入
產品
最近的發展

Kona Medical

公司簡介
公司收入
產品
最近的發展

Abbott

公司簡介
公司收入
產品
最近的發展

CardioSonic

公司簡介
公司收入
產品
最近的發展

Renal Dynamics Limited

公司簡介
公司收入
產品
最近的發展

Ablative Solutions

公司簡介
公司收入
產品
最近的發展

Symple Surgical

公司簡介
公司收入
產品
最近的發展

ReCor Medical

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11218375

The global demand for Renal Denervation Market is presumed to reach the market size of nearly USD 6023.78 MN by 2030 from USD 187.28 MN in 2022 with a CAGR of 54.32% under the study period 2023 - 2030.

In renal denervation (RDN), high-frequency extirpation is used to burn the nerve fibres of the renal arteries. This procedure reduces nerve activity and lowers blood pressure. Renal denervation is now preferred as a safe and less intrusive means of treating hypertension, resulting in permanent cessation of blood pressure medication. Renal denervation is an irreversible procedure.

MARKET DYNAMICS:

As per the findings, the key factors driving the renal devices market are the increased rate of hypertension and the procedure's long-term effectiveness. The advantages provided by this procedure, such as long-term effects, shorter treatment times, and increased safety, are anticipated to propel market growth. The availability of alternative and improved technology, such as micro-infusion, renal denervation systems, and enhanced healthcare infrastructure in emerging economies are other factors expected to drive the market growth during the study period. Despite this, several challenges are ahead of the renal denervation process, including that the process requires procuring the new device, which needs FDA approval, leading to a costly and time-consuming process.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of renal denervation. The growth and trends of renal denervation industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the renal denervation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Radiofrequency-Based
Ultrasound-Based
Micro-Infusion-Based

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Renal Denervation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the renal denervation market include Medtronic, Boston Scientific Corporation, Kona Medical, Abbott, CardioSonic, Renal Dynamics Limited, Ablative Solutions, Symple Surgical, ReCor Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . RENAL DENERVATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL RENAL DENERVATION MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Radiofrequency-based Historic and Forecast Sales by Regions
6.5 Ultrasound-based Historic and Forecast Sales by Regions
6.6 Micro-Infusion-based Historic and Forecast Sales by Regions

7 . GLOBAL RENAL DENERVATION MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE RENAL DENERVATION COMPANIES

8.1. Renal Denervation Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF RENAL DENERVATION INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Medtronic
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Boston Scientific Corporation
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Kona Medical
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Abbott
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. CardioSonic
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. Renal Dynamics Limited
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. Ablative Solutions
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Symple Surgical
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. ReCor Medical
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments